<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=601572900419438&amp;ev=PageView&amp;noscript=1">


About Northway Biotech US

Northway Biotech is a flexible biologics CDMO with a facility in a Greater Boston area, a world-leading hub in the field of life sciences research and drug development.

Our global teams based in the US and Europe are exceptionally well-versed in all aspects of the biopharmaceutical value chain, from cell line development to commercial production and aseptic fill-finish.

Our brand new, state-of-the-art facilities include R&D labs for cell line development, USP and DSP processes establishment and analytical support. cGMP manufacturing suite with both single-use and stainless steel systems for upstream and downstream process development, formulation and fill-finish of microbial and mammalian cell culture-based products will be fully functional in 2021.

We are deeply invested in providing high quality, world-class CDMO services and long-term partnerships based on our blend of experience and openly collaborative project teams.


Management US

Vladas Bumelis}

Vladas Algirdas Bumelis, Ph.D.

Executive Chairman of BoD & Advisory Board

Dr. Vladas Bumelis is the Founder of Northway Biotech and Chairman of the company’s Board of Directors and Advisory Board. He has extensive experience in the pharmaceutical and biotech industries, having previously served as General Manager of Sicor Biotech UAB (now Teva Pharmaceutical Industries Ltd.), Chairman of the Board for the biotech companies Biofa and Biotechna, and Chairman of the Board and General Manager of the Institute of Applied Enzymology in Lithuania. In 2004, Dr. V.Bumelis received the Science Award of Lithuania in recognition of his achievements in the development and production of recombinant proteins.

Vladas has a Ph.D. in chemistry, as well as a Ph.D. in biotechnology from Vilnius University, Lithuania.

Nick Maragos}

Nick Maragos

Vice President, Business Development

Nick Maragos holds a BSc in Biology from The University of Akron. He has over 25 years of Sales and Marketing experience coming from medical device and biotechnology companies. Nick most recently worked for Celonic and Rentschler Biopharma where he was responsible for Business Development both in Europe and the USA.


David Monson

Vice President, Business Development

David Monson has over two decades of technical sales expertise in the biopharmaceutical industry.  His prior experience in R&D, Manufacturing and Operations at early-stage developers like the Institute of Molecular Biology and Hybridon included the selection of qualified CDMO partners.  David’s expertise encompasses the entire biotherapeutic development lifecycle, including quality assurance and regulatory compliance.  His understanding of a developer’s specific needs enables better collaboration and his ability to advocate more effectively for clients. Prior to joining Northway, David held business development roles of increasing responsibility at Avecia, KBI and Celonic.  He earned a BSc in Biology/Marine Biology and Chemistry at Roger Williams University.